PGX

(redirected from pharmacogenetics)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to pharmacogenetics: Pharmacogenomics
AcronymDefinition
PGXPharmacogenomics
PGXPharmacogenetics
PGXPolyglycoplex ( InovoBiologic Ltd., Canada)
PGXPerigueux, France (Airport Code)
PGXPhotogray Extra (eyeglass lenses)
PGXPinoy Gold Exchange
References in periodicals archive ?
Hicks JK, Bishop JR, Sangkuhl K, et al; Clinical Pharmacogenetics Implementation Consortium.
Using pharmacogenetics testing data to select the appropriate drug and dosage for the patient can have considerable benefits for all stakeholders.
2010 Jan;26 Suppl 10:S16-20), which found that pharmacogenetic testing can help identify patients who are more likely to respond to opioid treatment, exactly which opioids would produce the most favorable responses, which patients would be at higher risks for opioid-related adverse events and drug interactions, and which patients would require higher-than-average opioid doses.
Study authors also acknowledged that their pharmacogenetic algorithms showed significant differences of predictability across different ethnic groups and that these algorithms performed better at predicting the optimal maintenance doses for nonblack patients than they did at predicting such doses for black patients.
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
Moreover it is already successfully applied at the bedside as a powerful pharmacogenetic marker.
Professor Munir Pirmohamed, who is leading the pioneering programme, said: "The study of pharmacogenetics is vital to the public health of this country
Professor Pirmohamed said: "The study of pharmacogenetics is vital to the public health of this country.
It has also released comments received on draft reflection paper on the use of pharmacogenetics in the pharmacokinetic evaluation of medicinal products http://www.
Testing for neuro-psychiatric disorders are expected to eventually dominate pharmacogenetics, increasing from 50,000 in 2006, to 9 million in 2013.
The study of how genetic factors influence a person's response to a drug is called pharmacogenetics.